A detailed history of Mercer Global Advisors Inc transactions in Natera, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 9,345 shares of NTRA stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,345
Previous 7,085 31.9%
Holding current value
$1.57 Million
Previous $767,000 54.76%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$97.75 - $129.67 $220,915 - $293,054
2,260 Added 31.9%
9,345 $1.19 Million
Q2 2024

Aug 12, 2024

BUY
$85.28 - $112.6 $604,208 - $797,771
7,085 New
7,085 $767,000
Q4 2021

Feb 04, 2022

SELL
$86.26 - $119.0 $160,788 - $221,816
-1,864 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$100.17 - $126.36 $186,716 - $235,535
1,864 New
1,864 $208,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.